在英国和美国,新的mRNA疫苗试验测试了禽流感的保护. New mRNA vaccine trial tests bird flu protection in UK and US.

在英国和美国正在进行新的第三期临床试验,以测试一种基于mRNA的H5N1禽流感病毒疫苗. A new phase 3 clinical trial is underway in the UK and US to test an mRNA-based vaccine for the H5N1 bird flu virus. 这项研究涉及约4000名参与者,旨在评估疫苗的安全性和引发免疫反应的能力. Involving about 4,000 participants, the study aims to assess the vaccine's safety and ability to trigger an immune response. 研究人员强调需要积极准备,因为病毒在动物中不断演变和传播. Researchers emphasize the need for proactive preparation as the virus evolves and continues to spread among animals.